ABSTRACT Polymorphisms in the ␤2 adrenergic receptor (ADRB2), in particular G16R, Q27E, and T164I, have been implicated in the pathogenesis of cardiovascular and metabolic phenotypes. However, no prospective, genetic-epidemiological data are available on the risk of cardiovascular disease associated with these variants. Using DNA samples collected at baseline in a prospective cohort of 14,916 initially healthy American men, we evaluated the G16R, Q27E, and T164I polymorphisms among 523 individuals who subsequently developed myocardial infarction and among 2092 individuals who remained free of reported cardiovascular events during follow-up. The haplotype frequency distribution was significantly different among cases and controls ( 2 7d.f. ϭ 20.92, P ϭ 0.0039). Haplotype-based logistic regression, adjusting for age, smoking, and randomized treatment group, indicated that G16-Q27-I164 (odds ratio 0.178, 95% C.I. 0.043-0.737, P ϭ 0.017) and (non-G16-Q27)-T164 (odds ratio 1.235, 95% C.I. 1.031-1.480, P ϭ 0.022) haplotypes were significantly associated with altered risk of myocardial infarction. These findings remained after further adjustment for BMI, history of hypertension, and presence or absence of diabetes. In conclusion, variation in haplotype frequencies for the ␤2 adrenergic receptor gene was found to be associated with risk of myocardial infarction.
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MATERIALS AND METHODS
T HE ␤2 adrenergic receptor (ADRB2), a member of the G-protein-coupled receptor superfamily, and vided an adequate sample of whole blood at baseline and had a confirmed MI, ischemic stroke, or venous thrombosis during these polymorphisms have been implicated in various follow-up was matched wherever possible to two or three concardiovascular and noncardiovascular disease phenotrols. The controls were study participants who had also protypes, including essential hypertension, asthma, obesity, vided a baseline blood sample and who remained free of any and type 2 diabetes (Drysdale et al. 2000 ; Hoffstedt reported cardiovascular disease at the time the index event et al. 2001; Herrmann et al. 2002; Kay et al. 2003) . occurred in the case patient. Controls were selected at random from among those who met the matching criteria of age (Ϯ2 However, to date, no prospective, genetic-epidemiologiyears), smoking habits, and time since study entry. As precal data are available on the risk of athero-thrombotic viously described (Steering Committee of the Physicians' disease. We therefore examined the role of G16R, Q27E, power for statistical analysis, all controls were pooled in a regression analysis with baseline-haplotype parameterization common reference group. A total of 523 cases of incident MI (Wallenstein et al. 1998) , adjusting for age, body mass index and 2092 controls were available for the current analysis. The (BMI), hypertension, smoking habits, diabetes, and randomstudy was approved by the Brigham and Women's Hospital ized aspirin/␤-carotene treatment assignment. This parameInstitutional Review Board for Human Subjects Research.
terization approach, using an additivity assumption, is particuGenotyping: Genotype determination for the ADRB2 polylarly appropriate for case-control studies. A global test statistic, morphisms was accomplished using multiplex PCR and immocomparing the model with genetic data to the model without bilized probe-based assays developed for multi-locus variant genetic data using the likelihood-ratio test, was also performed detection (Roche Molecular Systems, Alameda, CA) essentially to check for the overall association of haplotypes with the as described elsewhere (Cheng et al. 1999; Zee et al. 2002) . disease outcome. For each odds ratio, we calculated 95% conGenotype scoring was carried out by two independent observfidence intervals (C.I.'s). A two-tailed P-value of 0.05 was coners. Discordant results (Ͻ2%) were resolved by a further joint sidered a statistically significant result. reading and, where necessary, by a repeat genotyping. All results were scored blinded to case-control status. Because of the rarity of the I164 allele observed in the case group, a RESULTS second method, polymerase chain reaction-restriction fragment length polymorphism as described by Kay et al. (2003) , Baseline characteristics of the study population are was used to regenotype the entire case group, and we found shown in Table 1 significantly different between cases and controls only mated from genotype data using the partition ligation-expectation maximization algorithm (Qin et al. 2002) . Haplotype disfor T164I (P ϭ 0.0022; Table 2 ). The polymorphisms tributions were compared between cases and controls by a tested were in strong LD among one another (Table 3) .
likelihood-ratio test (Terwilliger and Ott 1994) . A likeliFurther analysis using haplotypic information showed a hood-ratio statistic was computed from the estimated haplosignificant difference in haplotype distribution between type frequency likelihoods for cases and controls separately cases and controls (P ϭ 0.004; Table 4 ). As shown in vs. combined. In addition, the relationship between the haplotypes and risk of MI was examined by a haplotype-based logistic these haplotypes were not included in the haplotypebased logistic regression analysis. As also shown in Table   2 7d.f. ϭ 20.92; P -value for likelihood-ratio test ϭ 0.00389.
4, virtually all of the I164 carriers were G16-Q27 whereas a minority of the T164 carriers were G16-Q27, a result of an apparent linkage disequilibrium between the G16-that haplotypes G16-Q27-I164 and (non-G16-Q27)-Q27 haplotype and the T164 allele. Thus, the haplotype T164, as compared to the reference haplotype G16-Q27-patterns were further collapsed and stratified using T164 T164, were significantly associated with an altered risk vs. I164 and G16-Q27 vs. non-G16-Q27 as presented of MI, suggesting a role for the G16-Q27 combination in Table 5 . Further analysis of the combined-genotype in addition to the individual protective effect of T164I distribution after excluding the T164I heterozygotes polymorphism. yielded similar significant results (P Ͻ 0.0001; appen-
The I164 allele has recently been shown to display dix). Thus, G16-Q27-T164 was used as the baseline hapa threefold reduction in receptor affinity, a markedly lotype for the regression analysis. Results from the crude depressed basal and agonist-stimulated adenylyl cyclase logistic regression analysis showed significant associaactivity, an impaired stabilization of mast cells, and a tion between haplotype patterns G16-Q27-I164 and decrease in adipocyte sensitivity as compared to the (non-G16-Q27)-T164 with risk of MI (P ϭ 0.017 and T164 allele (Drysdale et al. 2000 ; Hoffstedt et al. P ϭ 0.022, respectively; et al. 2003) . Moreover, the I164 allelic form of the findings (P ϭ 0.022 and P ϭ 0.015, respectively; Table receptor has been associated with increased downregu-6). The global test statistic-comparing the model with lation as compared to the T164 form (Green et al. 1993) . genetic data to the model without-again showed simiInterestingly, a recent report by Liggett et al. (1998) , lar significant results (crude, P Ͻ 0.001; adjusted, P Ͻ examining the role of G16R, Q27E, and T164I polymor-0.001; Table 6 ). The haplotype-based logistic regression phisms in heart failure, has shown an association of the approach proposed by Wallenstein et al. (1998) to T164I polymorphism with the outcome of patients with analyze the data in the present study was made possible congestive heart failure; individuals with heart failure by the particular LD pattern among the three polymorcarrying the I164 allele were at significant risk for rapid phisms investigated, which allowed unambiguous asprogression as compared to those carrying the T164 signment of haplotype pairs to each individual (confiallele. However, this finding was based on only 10 padence level for the haplotype estimation and inference Ͼ99.90%). Virtually identical study results were ob- found a significant protective effect of the T164I variant (non-G16-Q27)-I164 0.000 0.000 with MI. As previously reported, strong linkage disequilibrium was observed among the three polymorphisms.
Non-G16-Q27 is G16-E27, R16-Q27, and R16-E27 combined. a P -value for likelihood-ratio test. D'amato et al. (1998) examining the association of ity of heterogenous interaction observed between G16R G16R and Q27E with bronchial hyperresponsiveness and Q27E. These results do, however, suggest the impor-(BHR) using haplotypic information found an increased tance of including a haplotype-based analysis, as others frequency of the G16-Q27 haplotype among BHR-posihave recommended (Schaid 2002; Schaid et al. 2002) , tive subjects, suggesting that this haplotype may be an for proper assessment of multi-locus genetic association independent risk marker for BHR. In experimental studies (Johnson and Terra 2002). studies, the G16 and Q27 alleles have been indepenThe Physician's Health Study cohort is almost excludently associated with increased downregulation (Green sively composed of Caucasian middle-aged men, and et al. 1994, 1995) , further suggesting that this haplotype therefore the present data may not be generalized to carrying these allelic forms has the greatest potential other ethnic groups, women, or other populations. Nonefor receptor downregulation. Interestingly, in our investheless, there are considerable strengths of our present tigation, a discrepancy was observed between the prestudy design. It is a large prospective, nested case-control specified combined-genotype analysis (appendix) and cohort in which the determination of case status is based the haplotype-based analysis (Table 5 ) on G16R and solely on the subsequent development of disease rather Q27E with risk of MI. The G16R16-Q27Q27 combined than on arbitrary selection criteria. The background genotype is common among the cases, but has a relaallele frequencies observed in our control group were tively low frequency among the controls. On the other similar to those previously reported in other populahand, the G16R16-Q27E27 combined genotype is comtions (D'amato et al. 1998; Liggett et al. 1998 In conclusion, on the basis of the studied population, one R16 and one E27 is associated with reduced risk.
we found an association of the ␤2 adrenergic receptor The discrepancy might result from the nature of the gene variants with altered risk of myocardial infarction. additivity assumption that underlies the haplotype-based Furthermore, if replicated in other studies, our findings logistic regression approach used and/or suggest addiprovide further evidence of an important role for the tional complexity of heterogeneous interaction between ADRB2 gene and its variants in athero-thrombotic dis-G16R and Q27E.
orders. Taken together, our observed associations of the T164I
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in athero-thrombotic disease, although the exact mech-
